Dexcom (DXCM): Voleon Capital Management LP added to its stake +19K shares
Voleon Capital Management LP added to its stake in Dexcom, per its Q1 2025 13F.
- 77K
- Shares reported · +19K vs prior quarter
- 0.41%
- Disclosed portfolio weight
- $5.27M
- Reported value
- Holdings as of
- Mar 31, 2025
- Filed
- May 16, 2025
What stands out in this filing
- 57,922 shares in Q4 2024, 77,110 now (+33.1% in share count).
- Reported at $5.27M, 0.41% of the portfolio value in this 13F filing.
- 48 other tracked managers reported the same kind of change for Q1 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 25, 2025CongressDisclosed purchase of DXCM — reported range $1,001 - $15,000
- Mar 17, 2025InsiderDirector sold ~$25K of DXCM shares in the open market
- Apr 7, 2025CongressDisclosed sale of DXCM — reported range $15,001 - $50,000
- Apr 8, 2025CongressDisclosed sale of DXCM — reported range $1,001 - $15,000
- Apr 9, 2025FDAFDA device clearance: Dexcom G7 15 Day Continuous Glucose Monitoring System
- May 5, 2025FDARecall: Dexcom G7 iOS Application, Ref: SW12300 used in conjunction with the Dexcom G7 Continuous Glucose Monitoring (CGM) system
- May 8, 2025CongressDisclosed purchase of DXCM — reported range $15,001 - $50,000
- May 12, 2025FDARecall: Dexcom One+ Continuous Glucose Monitoring System, SKU(Part Number): STK-D7-013 (MT28285-1), STK-D7-014 (MT28285-1), STK-D7-103 (MT28285-2)
- May 12, 2025FDARecall: Dexcom One Continuous Glucose Monitoring System, SKUs(Part Number): STK-DO-006 (MT27409-1), STK-DO-013 (MT27409-1), STK-DO-103 (MT27409-2), STK-DO-109 (MT27409…
- May 12, 2025FDARecall: Dexcom G6 Glucose Receiver, SKUs (Part Number): STK-FM-001 (MT27408-1) & STK-FR-001 (MT27408-1)
- May 12, 2025FDARecall: Dexcom G7 Glucose Receiver, SKUs (part number): STK-AT-011(MT26403-0), STK-AT-012 (MT26403-0), STK-AT-013 (MT26403-0), STK-GT-001 (MT26403-1), STK-GT-008 (MT26…
- May 12, 2025CongressDisclosed sale of DXCM — reported range $15,001 - $50,000
- May 15, 2025CongressDisclosed purchase of DXCM — reported range $1,001 - $15,000
What came next
- May 23, 2025InsiderOfficer sold ~$843K of DXCM shares in the open market
- May 27, 2025InsiderOfficer sold ~$526K of DXCM shares in the open market
- Jun 13, 2025InsiderDirector sold ~$214K of DXCM shares in the open market
- Jun 16, 2025Insider · 3 peopleInsiders: 3 sales (~$574K)
- Jun 26, 2025InsiderOfficer sold ~$125K of DXCM shares in the open market
- Jul 15, 2025Insider · 2 peopleInsiders: 3 sales (~$277K)
- Jul 24, 2025FDARecall: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM Android App Model/Catalog Number: SW12299 Software Version: version 2.8.…
- Jul 24, 2025FDARecall: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ Android CGM App Model/Catalog Number: SW14245 Software Version: versions…
- Jul 24, 2025FDARecall: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App Model/Catalog Number: SW13355 Software Version: versions 2.8…
- Jul 24, 2025FDARecall: Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App Model/Catalog Number: SW14244 Software Version: versions 1.4…
- Jul 24, 2025FDARecall: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App Model/Catalog Number: SW12300 Software Version: version 2.8.0 an…
- Jul 28, 2025InsiderOfficer sold ~$130K of DXCM shares in the open market
- Aug 15, 2025Insider · 2 peopleInsiders: 3 sales (~$263K)
- Aug 27, 2025Layoff notice · 6290-6350 Sequence Drive San Diego CA 92121Layoff notice filed in CA: 319 employees
- Aug 28, 2025FDARecall: Brand Name: Dexcom G6 Continuous Glucose Monitoring System Product Name: Dexcom G6 and G6 Pro Android US CGM App Model/Catalog Number: SW11678 Software Version…
- Sep 2, 2025InsiderOfficer sold ~$358K of DXCM shares in the open market
- Sep 4, 2025InsiderOfficer sold ~$117K of DXCM shares in the open market
- Sep 5, 2025InsiderDirector sold ~$54K of DXCM shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Dexcom
For Dexcom, OQRO holds 20 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DXCM page.
How this filing works
Explore the data
Common questions
What does this filing report about Dexcom (DXCM) stock?
Voleon Capital Management LP added to its stake in Dexcom, per its Q1 2025 13F. Now 77K shares, $5.27M reported value, 0.41% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2025. Filed: May 16, 2025.
What stands out in this filing?
57,922 shares in Q4 2024, 77,110 now (+33.1% in share count). Reported at $5.27M, 0.41% of the portfolio value in this 13F filing. 48 other tracked managers reported the same kind of change for Q1 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Dexcom recently?
For Dexcom, OQRO holds 20 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the DXCM page.
Does this mean DXCM stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Dexcom
- SEC Form 4Nov 18, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 16, 2026
- SEC Form 4Oct 28, 2026
- SEC Form 144Oct 27, 2026
- SEC Form 4Oct 19, 2026
Everything OQRO holds on this company is on its DXCM page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
